Condition

Cancer of Prostate

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 36 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials36
Recruiting6
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

36 shown
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderNCT07072728 · 2025-10-01
RECRUITING
Investigation of Three Biomarkers for the Detection of Prostate CancerNCT06554587 · 2025-01-07
RECRUITING
The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer PatientsNCT06406803 · 2024-10-12
RECRUITING
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate CancerNCT05600400 · 2024-03-01
RECRUITING
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D InterventionNCT06318559 · 2022-06-29
RECRUITING
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer SurvivorsNCT05214937 · 2022-02-15
RECRUITING
Neoadjuvant SGLT2 Inhibition in Localized Prostate CancerNCT04887935 · 2024-06-04
TERMINATED
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerNCT05653063 · 2023-12-07
ACTIVE_NOT_RECRUITING
Real-time Motion Management During Prostate and Lung RadiotherapyNCT05844761 · 2023-05-01
ACTIVE_NOT_RECRUITING
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCNCT05191017 · 2022-09-01
WITHDRAWN
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNCT05252390 · 2022-03-29
TERMINATED
Retzius-sparing Technique in Robotic-assisted Radical ProstatectomyNCT05224024 · 2022-02-15
UNKNOWN
Onco-primary Care Networking to Support TEAM-based CareNCT04258813 · 2021-06-14
ACTIVE_NOT_RECRUITING
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMANCT04319783 · 2021-06-02
ACTIVE_NOT_RECRUITING
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNCT04541225 · 2020-12-08
TERMINATED
Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgrammeNCT04304196 · 2020-06-01
COMPLETED
Hypertension Management in Cancer PatientsNCT03919214 · 2019-12-10
TERMINATED
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPNCT03899077 · 2019-04-05
UNKNOWN
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)NCT03896958 · 2019-03-21
UNKNOWN
De-implementation of Low Value Castration for Men With Prostate CancerNCT03579680 · 2018-08-22
COMPLETED
Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With InsomniaNCT03444532 · 2018-03-02
COMPLETED
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate CancerNCT03450109 · 2017-12-22
COMPLETED
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic BiopsyNCT03442075 · 2017-05-01
COMPLETED
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)NCT03133286 · 2017-04-06
COMPLETED
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)NCT03031418 · 2016-09-01
COMPLETED
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer SurvivorsNCT02957357 · 2016-02-01
COMPLETED
Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer PatientsNCT02614859 · 2015-12-01
COMPLETED
Prostatic Cancer Versus Androgen DeficiencyNCT02235142 · 2013-06-03
COMPLETED
Sipuleucel-T Manufacturing Demonstration StudyNCT01477749 · 2012-06-01
COMPLETED
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer FociNCT01639859 · 2011-10-01
COMPLETED
Dynamic Focusing Evaluation for Prostate Cancer TreatmentNCT03632980 · 2011-06-01
UNKNOWN
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)NCT02564120 · 2011-01-01
COMPLETED
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy SimulatorNCT00999960 · 2010-02-01
TERMINATED
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerNCT00970203 · 2009-09-01
COMPLETED
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerNCT00220194 · 2003-04-01
COMPLETED
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyNCT00257478
COMPLETED

Common interventions

Trial status mix

COMPLETED16
RECRUITING6
TERMINATED5
ACTIVE_NOT_RECRUITING4
UNKNOWN4
WITHDRAWN1

Phase mix

NA15
PHASE28
PHASE15
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.